APA (7th ed.) Citation

LM, R. (2024). Editorial commentary: Understanding the cardiovascular benefits of glucagon-like peptide-1 (GLP-1) receptor agonists. Trends in cardiovascular medicine, 34(8), 558. https://doi.org/10.1016/j.tcm.2024.03.007

Chicago Style (17th ed.) Citation

LM, Raven. "Editorial Commentary: Understanding the Cardiovascular Benefits of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists." Trends in Cardiovascular Medicine 34, no. 8 (2024): 558. https://doi.org/10.1016/j.tcm.2024.03.007.

MLA (9th ed.) Citation

LM, Raven. "Editorial Commentary: Understanding the Cardiovascular Benefits of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists." Trends in Cardiovascular Medicine, vol. 34, no. 8, 2024, p. 558, https://doi.org/10.1016/j.tcm.2024.03.007.